Presentation at the 2024 International HBV Meeting Highlights Antiviral Activity of EBT-107 as a Potential Anti-HBV Therapy
Excision BioTherapeutics today announced that it presented data from its program for Hepatitis B virus, EBT-107, at the 2024 International HBV Meeting